Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation

H Yang, Y Liu, F Bai, JY Zhang, SH Ma, J Liu, ZD Xu… - Oncogene, 2013 - nature.com
The TET (ten–eleven translocation) family of α-ketoglutarate (α-KG)-dependent
dioxygenases catalyzes the sequential oxidation of 5-methylcytosine (5mC) to 5 …

TET proteins and the control of cytosine demethylation in cancer

L Scourzic, E Mouly, OA Bernard - Genome medicine, 2015 - Springer
The discovery that ten-eleven translocation (TET) proteins are α-ketoglutarate-dependent
dioxygenases involved in the conversion of 5-methylcytosines (5-mC) to 5 …

Dysregulation of the TET family of epigenetic regulators in lymphoid and myeloid malignancies

CWJ Lio, H Yuita, A Rao - Blood, The Journal of the American …, 2019 - ashpublications.org
DNA methylation has pivotal regulatory roles in mammalian development, retrotransposon
silencing, genomic imprinting, X-chromosome inactivation, and cancer. Cancer cells display …

Loss of Tet1-associated 5-hydroxymethylcytosine is concomitant with aberrant promoter hypermethylation in liver cancer

JP Thomson, R Ottaviano, EB Unterberger… - Cancer research, 2016 - AACR
Aberrant hypermethylation of CpG islands (CGI) in human tumors occurs predominantly at
repressed genes in the host tissue, but the preceding events driving this phenomenon are …

Loss of 5‐hydroxymethylcytosine is accompanied with malignant cellular transformation

Y Kudo, K Tateishi, K Yamamoto, S Yamamoto… - Cancer …, 2012 - Wiley Online Library
Dysregulated DNA methylation followed by abnormal gene expression is an epigenetic
hallmark in cancer. DNA methylation is catalyzed by DNA methyltransferases, and the …

[HTML][HTML] Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers

MC Haffner, A Chaux, AK Meeker, DM Esopi, J Gerber… - Oncotarget, 2011 - ncbi.nlm.nih.gov
DNA methylation at the 5-position of cytosines (5mC) represents an important epigenetic
modification involved in tissue differentiation and is frequently altered in cancer. Recent …

Decrease of 5-hydroxymethylcytosine is associated with progression of hepatocellular carcinoma through downregulation of TET1

C Liu, L Liu, X Chen, J Shen, J Shan, Y Xu, Z Yang… - PloS one, 2013 - journals.plos.org
DNA methylation is an important epigenetic modification and is frequently altered in cancer.
Convert of 5-methylcytosine (5 mC) to 5-hydroxymethylcytosine (5 hmC) by ten-eleven …

Epigenetic downregulation of TET3 reduces genome‐wide 5hmC levels and promotes glioblastoma tumorigenesis

A Carella, JR Tejedor, MG García… - … journal of cancer, 2020 - Wiley Online Library
Loss of 5‐hydroxymethylcytosine (5hmC) has been associated with mutations of the ten–
eleven translocation (TET) enzymes in several types of cancer. However, tumors with wild …

TET family dioxygenases and DNA demethylation in stem cells and cancers

J An, A Rao, M Ko - Experimental & molecular medicine, 2017 - nature.com
The methylation of cytosine and subsequent oxidation constitutes a fundamental epigenetic
modification in mammalian genomes, and its abnormalities are intimately coupled to various …

TET2 as an epigenetic master regulator for normal and malignant hematopoiesis

H Nakajima, H Kunimoto - Cancer science, 2014 - Wiley Online Library
DNA methylation is one of the critical epigenetic modifications regulating various cellular
processes such as differentiation or proliferation, and its dysregulation leads to disordered …